Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LAURUS LABS Gains 4%; BSE HEALTHCARE Index Up 1.0%
Tue, 10 Sep 12:4

LAURUS LABS  Gains 4%; BSE HEALTHCARE Index Up 1.0%Image source: phive2015/www.istockphoto.com

LAURUS LABS share price has zoomed 4% and is presently trading at Rs 510.2.

Meanwhile, the BSE HEALTHCARE index is at 43,787.7 (up 1.0%).

Among the top gainers in the BSE HEALTHCARE index today are FDC (up 6.8%) and AJANTA PHARMA (up 3.6%).

NARAYANA HRUDAYALAYA (down 1.8%) and ERIS LIFESCIENCES (down 1.7%) are among the top losers today.

Over the last one year, LAURUS LABS has moved up from Rs 407.2 to Rs 510.2, registering a gain of Rs 103.0 (up 25.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,357.7 to 43,787.7, registering a gain of 54.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 135.8%), Jubilant Pharmova (up 126.1%) and GRANULES INDIA (up 119.4%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,840.0 (up 0.3%).

The top gainers among the BSE Sensex today are Bharti Airtel (up 1.5%) and Infosys (up 1.4%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 25,024.6 (up 0.4%). Divis Laboratories and LTIMINDTREE are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,880.5 to 81,840.0, registering a gain of 15,959.5 points (up 24.2%).

LAURUS LABS Financial Update...

LAURUS LABS net profit fell 57.0% YoY to Rs 122 million for the quarter ended June 2024, compared to a profit of Rs 284 million a year ago. Net sales rose 1.1% to Rs 11,949 million during the period as against Rs 11,818 million in April-June 2023.

For the year ended March 2024, LAURUS LABS reported 78.9% decrease in net profit to Rs 1,682 million compared to net profit of Rs 7,966 million during FY23. Revenue of the company fell 16.6% to Rs 50,408 million during FY24.

The current Price to earnings ratio of LAURUS LABS , based on rolling 12 month earnings, stands at 180.9.


Equitymaster requests your view! Post a comment on "LAURUS LABS Gains 4%; BSE HEALTHCARE Index Up 1.0%". Click here!